This content is machine translated Systemic lupus erythematosus New possibilities for SLE therapy The core of the previous classification criteria for systemic lupus erythematosus (SLE) originated in 1982 and were only slightly modified in 1997. It is therefore high time to address the…
View Post 2 min This content is machine translated Multiple sclerosis Individual life situation in the focus of effective therapy Intensive research in the field of multiple sclerosis (MS) has led to the availability of different treatment options – depending on the form of the disease and its severity. Until…
View Post 5 min This content is machine translated Chronic coronary syndrome Risk stratification in coronary artery disease – an update. Coronary CT is highly ranked for the work-up algorithm in the updated European Society of Cardiology (ESC) guidelines. Calcification is an important prognostic indicator and has therapeutic implications. Among other…
View Post 5 min This content is machine translated Bacterial microflora The microbiome – our second genome Commensal microbes in the skin and mucosa play a key role in regulating the immune system and maintaining health. Influences that lead to a change in the composition of the…
View Post 5 min This content is machine translated Inflammatory rheumatic joint diseases Broad spectrum of differential diagnoses A timely correct diagnosis can positively influence the course and treatment options. Auto-antibodies and other serological parameters are diagnostically valuable, but do not have high significance when considered in isolation.…
View Post 2 min This content is machine translated Bladder Cancer Immunotherapy after chemo may prolong survival Carcinoma of the urinary bladder is one of the common malignant diseases. While the prognosis of patients with superficial tumors is usually favorable, the situation is much worse for muscle-infiltrating…
View Post 5 min This content is machine translated Chronic rhinosinusitis The right nose with biologics Rhinosinusitis is divided into two groups: chronic with nasal polyps (CRSwNP) and those without (CRSsNP). It is a common disease, affecting about 11% of the population throughout Europe. Therapeutic options…
View Post 3 min This content is machine translated Hematologic malignancies Lymphocytic lymphomas and leukemias: focus on current therapies Malignant hematologic diseases such as leukemias or lymphomas represent the fourth most common cancer and affect approximately 20/100,000 population per year in Europe. A number of effective substances are now…
View Post 6 min This content is machine translated Inflammatory dermatoses Not only the right wavelength is decisive Laser medicine applications as second-line or adjuvant therapy can be a valuable addition to the treatment spectrum for inflammatory dermatoses. For best possible results, treatment decisions must be weighed on…
View Post 3 min This content is machine translated Rheumatic diseases How do antirheumatic drugs correlate with COVID-19 courses? Whether the use of immunosuppressants increases the risk of a severe course in SARS-CoV-2 infection is as yet unclear. A study published in advance of the European Congress of Rheumatology…
View Post 2 min This content is machine translated Immunotherapy Keeping an eye on iron status during tumor therapy Iron deficiency is not only common in malignancies, but also a risk factor for impaired efficacy of antitumor treatment. Accordingly, transferrin saturation should be kept in view and iron supplementation…
